Item

Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): primary analysis of Ph3 DeLLphi-304

Rudin, C. M.
; 
Mountzios, G. S.
; 
Sun, L. H.
; 
Cho, B. C.
; 
Demirci, U.
; 
Baka, S.
; 
Gumus, M.
; 
Lugini, A.
; 
Ciuleanu, T. E.
; 
Ahn, M. J.
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Rudin, C. M.
Mountzios, G. S.
Sun, L. H.
Cho, B. C.
Demirci, U.
Baka, S.
Gumus, M.
Lugini, A.
Ciuleanu, T. E.
Ahn, M. J.
Rocha, P.
Zhu, B.
Blackhall, F. H.
Yoshida, T.
Owonikoko, T. K.
Paz-Ares, L. G.
Huang, S.
Gauto, D. M.
Recondo, G.
Schuler, M.
Affiliation
Mem Sloan Kettering Canc Ctr, Fiona & Stanley Druckenmiller Ctr Lung Canc Res, New York, NY USA Henry Dunant Hosp Ctr, Dept Med Oncol 4, Athens, Greece Henry Dunant Hosp Ctr, Clin Trials Unit, Athens, Greece Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea Mem Ankara Hosp, Ankara, Turkiye Interbalkan European Med Ctr, Thessaloniki, Greece Istanbul Medeniyet Univ Hosp, Med Oncol Unit, Istanbul, Turkiye Azienda Osped AO San Giovanni Addolorata Hosp, Rome, Italy Inst Oncol Prof Dr Ion Chiricuta, Cluj Napoca, Romania Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea Vall dHebron Univ Hosp, Barcelona, Spain Army Med Univ, Affiliated Hosp 2, PLA, Chongqing, Peoples R China Christie NHS Fdn Trust, Manchester, England Univ Manchester, Manchester, England Natl Canc Ctr, Tokyo, Japan Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD USA Hosp Univ 12 Octubre, Ciberonc, CNIO H120 Lung Canc Unit, Madrid, Spain Univ Complutense, Madrid, Spain Amgen Inc, Thousand Oaks, CA USA Univ Hosp Essen, West German Canc Ctr, Essen, Germany
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Rudin CM, Mountzios GS, Sun LH, Cho BC, Demirci U, Baka S, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304. JOURNAL OF CLINICAL ONCOLOGY. 2025 JUN 10;43(17_SUPPL):LBA8008-LBA. PubMed PMID: WOS:001511754700001. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/628144
Embedded videos